Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spinal Biologics is a medical technology company focused on developing and commercializing innovative biologic solutions for spinal surgery and the treatment of degenerative disc disease. The company's product portfolio includes advanced bone graft substitutes, amniotic tissues, and cellular therapies designed to enhance the body's natural healing processes and improve patient outcomes in spinal fusion procedures. By leveraging regenerative medicine, Spinal Biologics aims to provide surgeons with effective alternatives to traditional autograft and allograft options. Their products are primarily used in orthopedic and neurosurgical applications to address chronic back pain and spinal instability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spinal Biologics.